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Fracture repair is initiated by a multitude of immune cells and induction of an inflammatory
cascade. Alterations in the early healing response due to an aged adaptive immune
system leads to impaired bone repair, delayed healing or even formation of non-union.
However, immuno-senescence is not limited to the adaptive immunity, but is also
described for macrophages, main effector cells from the innate immune system.
Beside regulation of pro- and anti-inflammatory signaling, macrophages contribute to
angiogenesis and granulation tissue maturation. Thus, it seems likely that an altered
macrophage function due to aging may affect bone repair at various stages and
contribute to age related deficiencies in bone regeneration. To prove this hypothesis,
we analyzed the expression of macrophage markers and angiogenic factors in the early
bone hematoma derived from young and aged osteotomized Spraque Dawley rats.
We detected an overall reduced expression of the monocyte/pan-macrophage markers
CD14 and CD68 in aged rats. Furthermore, the analysis revealed an impaired expression
of anti-inflammatory M2 macrophage markers in hematoma from aged animals that
was connected to a diminished revascularization of the bone callus. To verify that
the age related disturbed bone regeneration was due to a compromised macrophage
function, CD14+ macrophage precursors were transplanted locally into the osteotomy
gap of aged rats. Transplantation rescued bone regeneration partially after 6 weeks,
demonstrated by a significantly induced deposition of new bone tissue, reduced fibrosis
and significantly improved callus vascularization.
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HIGHLIGHTS
- Compromised bone regeneration in aged rats is connected to a reduced expression of the
pan-macrophage markers CD14 and CD68.
- Anti-inflammatory M2macrophage markers are decreased in the early callus from aged animals.
- Macrophage mediated angiogenesis is impaired in the early callus of aged animals.
- Transplantation of CD14 macrophage precursors rescues impaired bone regeneration in aged
rats partially.
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INTRODUCTION
Fracture repair is a highly orchestrated process that involves
a distinct pro- to anti-inflammatory signaling cascade in
the hematoma, angiogenesis, coordinated extracellular matrix
deposition and progression toward endochondral ossification
(1). Comorbidities associated with an altered immune response,
such as advanced age, diabetes, or rheumatoid arthritis,
have been shown to reduce the initial biological potential
of the fracture hematoma and may impair regeneration
(2–4). In addition, disturbances in the revascularization or
unbalanced expression of angiogenic growths factors can delay
bone regeneration and eventually lead to the formation of
atrophic pseudarthrosis (1, 5–8). Several studies report on the
interconnection of immune cells, inflammation, and angiogenic
processes. Especially monocytes and macrophages, cells from
the innate immune system, are reported to regulate bone
homeostasis and repair, as well as tissue vascularization (9, 10). In
this context, optimal fracture repair is steered by a collaboration
from infiltrating and bone-resident macrophages (11). In
dependence of their surroundings, activated macrophages
can adopt different functions that are characterized by a
pro-inflammatory M1 (classically activated), and an anti-
inflammatory M2 phenotype (alternatively activated). M1
macrophages produce large amounts of pro-inflammatory
cytokines, as TNFa and IL-1b, and induce Th1 responses. In
contrast, the so called M2 phenotype produces IL-10, IL-1
receptor type α, and TGF-β, induces Th2 immune responses,
and contribute to angiogenesis, wound healing progression
and granulation tissue maturation (12–16). Particularly M2
macrophages have shown to be highly diverse in their
functionality and activation patterns. Over the last years,
several M2 subsets have been identified (M2a, M2b, and M2c),
even repolarization toward M1 phenotypes has been observed,
highlighting the great plasticity of macrophages (17, 18).
However, detailed information on the diverse functions of
even the more simplified concept of M1 and M2 macrophages
during bone repair are rare. While Loi et al. demonstrated that a
transition fromM1 towardM2 phenotypes highly promotes bone
formation in vitro, studies analyzing the impact of the different
macrophage phenotypes in biologically compromised healing
situations, as advanced age, are missing (19). We hypothesized
that biologically impaired bone regeneration is connected to
disturbances in macrophage functionality and alterations in the
M1/M2 macrophage populations. To prove this hypothesis, we
investigated the impact of M1/M2 macrophages on bone healing
in aged rats more in detail.
MATERIALS AND METHODS
Animal Studies
For the in vivo animal studies 3 and 12 month old female
ex-breeder Sprague Dawley rats from Charles River WIGA
Deutschland GmbH were used. These aged rats, that had a
minimum of 3 L served as models for biologically impaired
fracture healing that develop a non-union, when no additional
treatment is applied (4, 20–22). Animal experiments were
conducted in compliance with the ARRIVE guidelines and
according to the policies and principles of the Animal Welfare
Act, the National Institutes of Health Guide for the Care
and Use of Laboratory Animals, and the National Animal
Welfare Guidelines. All animal experiments were approved by
the local legal representative (Institutional Animal Care and
Use Committees, LaGeSo, G0120/14, G0172/15). Animals were
anesthetized with 0.3 mg/kg Medetomidin DomitorH and 60
mg/kg Ketamin by intraperitoneal injection prior to surgical
procedure. Additionally, 20 mg/kg Tramadol was administered
as analgesia. Forty-five milligram per kilogram Clindamycin was
administered by subcutaneous injection and eyes were prevented
from drying out by application of eye balm. A longitudinal skin
incision was made over the left femur. The bone was exposed
by blunt fascia dissections. An in-house developed unilateral
external fixator was mounted to stabilize the bone, made of
stainless steel and titanium as published previously (20, 23). For
an exact placement of the four wire holes, a drilling template
was used for every procedure. After incision of the titanium
wires, the external fixator bar was placed on the wires and a
standardized 2mm gap was sawn by osteotomy into the femoral
bone. To ensure reproducibility of the gap size a sawing template
was used at all times. Muscle fascia and skin were closed using
absorbable and non-absorbable sutures, respectively. Animals
received an anesthetic antagonist and were placed under red light
until awakening. Post-surgical analgesia was given by addition of
Tramadol (25 ml/l) to the drinking water for 3 days. Fracture
healing was assessed after 3 and 7 days, as well as after 6 weeks
by euthanization and femur dissection. Animal IDs, weights and
group sizes can be found in Table 1.
Intraoperative Cell Transplantation
For the intraoperative cell transplantation of PBMCs or CD14+
cells into the osteotomy gap, 15ml cardiac blood were drawn
from 12-month-old donor rats. Subsequently, PBMCs were
isolated by application of a density gradient using Histopaque-
1083 (Sigma-Aldrich). The CD14+ subset was further extracted
from the PBMC population using positive Magnetic Activated
Cell Sorting by application of a murine CD14+ antibody (clone:
biG, Abnova), combined with anti-mouse IgG microbeads from
Miltenyi Biotec. Per blood clot 2 × 105 of either PBMCs
(including CD14+ cells) or CD14+ cells were re-suspended in
200µl autologous blood, that was drawn just prior to the surgical
procedure (including 10 µl sodium citrate, to prevent clotting).
The osteotomy procedure was performed as described above.
For cell transplantation groups, blood clotting was induced right
before the clot was placed into the osteotomy gap by adding 7
µl CaCl2 12%Thrombin (Baxter). The lid of a 1.5ml Eppendorf
tube served as a forming device for the artificial hematoma.
The clot was designed to exactly fit into the osteotomy gap
(same height as gap width), but with a slightly larger diameter,
to ensure that the osteotomy gap was spanned by the clot. No
differences in clot quality/nature were observed at any point. It
was previously shown, that bone formation after a regular healing
time of 6 weeks in animals receiving an empty autologous blood
clot without additional cell supplementation is comparable to the
one seen in animals that received a PBMC supplemented blood
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clot (24, 25) thus PBMC supplemented artificial hematoma was
used as control in this study rather than the autologous blood
clot alone.
µCT
Bone healing was assessed in vitro with micro-computed
tomography on formaldehyde-fixed left femurs extracted from


































euthanized animals 6 weeks after surgery. A region of interest
(ROI) covering the 2mm osteotomy gap plus 1mm proximal and
distal was scanned in a Viva CT 40 microCT (Scanco Medical
AG) with application of a voxel size of 10.5µm, 55 keVp, 145
µA. Bone microstructure trabecular number, trabecular space,
trabecular thickness) and the key parameters of tissue and bone
mineral content were assessed using the respective software
from the device supplier (Scanco Software, Scanco Medical
AG). 3D µCT reconstruction were done using CTvox (version
3.2.0.r1294). All analyses were performed in a blinded manner
by two different observers with automatically assignment of µCT
screen-numbers, to avoid bias to the treatment.
Fracture Hematoma Extraction and Gene
Expression Analysis
For gene expression analysis, femurs were excised from animals
euthanized 3 and 7 days after osteotomy. Surrounding muscle
tissue was dissected and tissue containing the fracture callus plus
1mm proximal and distal to the osteotomy gap was extracted
and immediately transferred to liquid nitrogen. Subsequently,
tissue samples were pestled while frozen in liquid nitrogen
and collected in TRIzol Reagent (LifeTechnologies) afterwards.
RNA was isolated according to the manufacturer’s protocol,
followed by determination of RNA concentration using a
Nano-Drop spectrophotometer. cDNA was transcribed from
25 ng/µl RNA with iScript reverse transcriptase as indicated
by the manufacturer (Bio-Rad Laboratories GmbH) and gene
expression was determined via quantitative real time PCR
(iQ5 Cycler, Bio-Rad Laboratories GmbH). Primer sequences
(Table 2) were generated using the primer 3 web based software
(http://primer3.ut.ee/) and tested for specificity (ePCR, http://
www.ncbi.nlm.nih.gov/tools/epcr/). Expression of each gene was
calculated according to the ddCT method with adjustment
for primer efficiency and normalization to TATA-box binding
protein (Tbp) expression by utilizing the REST software (26).
The housekeeping gene Tbp was tested against others (Gapdh,
TABLE 2 | Primer sequences.
Gene Gene name Forward 5′-3′ Reverse 5′-3′
CD14 Cluster of differentiation 14 aactgaagcctttctcggagc gcataagcttcatggtcggt
CD68 Cluster of differentiation 68 tccagcaattcacctggacc aagagaagcatggcccgaag
CD80 Cluster of differentiation 80 gctgctggttggtcttttcc ttcttgtactcgggccacac
CCR7 C-C chemokine receptor type 7 tacatcggcgagaacaccac caggacttggcttcgctgta
CD163 Cluster of differentiation 163 ctggagcatgaacgaggtgt ttcctgagcatcggttgtcc
CD206 Cluster of differentiation 206 cagtttgagggcagcaagag acactcaggagctcagcatt
Tie-2 TEK tyrosine kinase; angiopoetin receptor tctgctctcaaggatggcaa cacactgcagacccaaactc
Dectin C-type lectin domain family 7 member A (CLEC7A)/Dectin cgtcttttctggaccttgcc acggcccttcactctgattg
PDGFα Platelet derived growth factor alpha ttgaacatgacccgagcaca acacctctgtacgcgtcttg
PDGFRα Platelet derived growth factor receptor alpha agtgcttggtcggatcttgg gagcatcttcacagccacct
PDGFβ Platelet derived growth factor beta ttgaacatgacccgagcaca acacctctgtacgcgtcttg
PDGFRβ Platelet derived growth factor receptor beta cgttgcaggtggtgtttgag acacggacagggacattgac
HIF-1α Hypoxia-inducible factor 1, alpha subunit tcatcagttgccacttcccc actgggccatttctgtgtgt
VEGF Vascular endothelial growth factor aaagcccatgaagtggtgaa tctgcatagtgacgttgctc
VEFGR Vascular endothelial growth factor receptor agaacagagctcaacgtggg atctttgccacagtcccagg
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Actb, Eif4e, B2m) and was found to be the most stable gene in all
investigated samples.
Histological Analysis
Histological analyses were performed on frozen section
according to the Kawamoto’s film method (27). Excised femurs
were fixed in a 4% PBS/PFA solution for 24 h at 4◦C. For
cryo-protection purposes, femurs were transferred into 10, 20,
30% sucrose solutions in ascending order for 24 h at 4◦C at a
time, subsequently embedded in SCEM-Medium and frozen by
immersion into cold n-Hexan. Embedded and frozen samples
were sectioned into 5µm thick slices. All femurs were oriented
in the same manner for the histological analyses, where the
proximal part of the femur is placed on the left and the distal end
of the femur on the right side of the image.
To distinguish between different calcified and soft tissues
Movant Pentachrome staining was used. Prior to the staining
procedure, slides were fixed with 4% PFA/PBS for 15min.
Five subsequent stainings are applied to stain mineralized
bone (yellow/orange), collagen (yellow), cartilage (green/blue),
osteoid (dark red), elastic fibers (orange/red), and nuclei (blue-
black). After fixation samples were rehydrated for 5min before
alcian blue staining was applied for 30min, which targets
acid proteoglycans structures like chondroitin sulfate. One
hour incubation in alkaline ethanol, stabilizing the blue-green
pigment. Afterwards, slides were incubated in Weigert’s Iron
hematoxylin solution (15min), to stain nuclei. Cell plasma was
stained by brilliant crocein acid fuchsine (15min), followed by
differentiation in 0.5% acetic acid. As a last step, slides were
incubated in phosphotungstic acid (20min) and the connective
tissue was stained by saffron du gatinais solution.
Vascularization analysis was performed on smooth muscle
actin (αSMA) immunohistochemical staining. Slides were
fixed with 4% PFA/PBS prior to the staining procedure.
All subsequent staining steps were carried out in a humid
chamber, at room temperature, unless stated otherwise. To
block against unspecific background, samples were incubated
with 2% normal horse serum before overnight application of
the primary antibody (α-SMA, Dako M0851) at 4◦C. Thirty
minutes incubation with the secondary antibody (biotinylated
anti-mouse IGG, rat-adsorbed, made in horse) and subsequent
application of AB complex (ABC-AP Vectastain Kit—SP 5000)
for 50min. 2 × 5min incubation with chromogen buffer
before visualization of the vessels with AP- substrate (Red
AP Substrate Kit, Vector—SK 5100). Color development was
controlled under the microscope and ended by washing the
slides with PBS. Nuclei were counter stained using Mayers
Hämalaun for 1.5min, unstained surrounding tissue is blued by
tab water.
Pictures of the stained samples were taken with Zeiss
Axioscope 40 Microscope, 10× objective (plus condenser) and
the corresponding Imaging AxioVision LE Software (Carl Zeiss).
FIGURE 1 | M2 Macrophage function is impaired in bone hematoma of aged rats. (A) The general monocyte maker CD14 and the general mocrophage maker CD68
show a significant reduced expression 3 and 7 days after osteotomy in hematoma tissue extracted from aged animals compared to young ones. (B) The makers
CD80 and CCR7 that are predominantly expressed by M1 macrophages show higher expression levels in fracture callus tissue from aged animals at day 3. (C) Marker
genes that are mostly expressed by M2 macrophages (CD163, CD206, Tie-2, Dectin) show a significantly diminished expression in hematoma tissue from aged
animals compared to the expression found in fracture hematoma extracted from young animals. n = 4–5, *significant to young d3, *p < 0.05;**p < 0.001; #significant
to young d7, #p < 0.05; ###p < 0.001, ANOVA.
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Tissue quantification was done with ImageJ (Version 1.44p;
http://rsbweb.nih.gov/ij/) using a semi-automated method on
blinded sections. Vessels were counted manually in a blinded
approach. Inclusion criteria included a clear endothelial cell
border, a visible lumen and non-muscle association. A region of
interest (ROI) including the osteotomy gap and 1mm proximal
and distal to it was investigated.
Statistics
Determined values are depicted as bar charts showing mean
± standard deviation. For statistical analysis SigmaPlot 11.0
was used. Data were checked for normality distribution
and analyzed with Student’s t-test or ANOVA using a
Bonferroni correction. If normality distribution could not
be confirmed, data were analyzed using a non-parametric
Man Whitney U Test or a multiple pairwise comparison
according to Dunn’s method. A p ≤ 0.05 was considered
as significant. Each analysis was performed with three
technical replicates per biological samples. The applied
statistical method and the amount of individual biological
samples (n) that were analyzed are indicated in the respective
figure legends.
FIGURE 2 | Bone callus vascularization is compromised in aged rats. (A) Expression of the angiogenic transcription factor HIF-1α, the angiogenic growth factors
PDGFα and VEGF and their respective receptors PDGFRα, PDGFRβ, and VEGFR is significantly reduced in callus tissue from aged rats extracted 3 and 7 days after
osteotomy. n = 4–5, *significant to young d3; #significant to young d7, ANOVA on Ranks. (B) Vessel number evaluated in αSMA stained tissue sections. For each
condition, the left picture shows the overview of the whole region of interest, the right picture shows the magnification of the region within the square–found in the
respective overview mage. Femurs are placed in the same orientation, with the proximal side on the left and distal on the right side. y/d3, y/d7 n = 5, a/d3 n = 3, a/d7
n = 6, *significant to young d3, *p < 0.05, ***p < 0.001; #significant to young d7, #p < 0.05, ###p < 0.001, ANOVA.
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RESULTS
Diminished Macrophage Accumulation in Bone
Callus of Aged Rats
To validate our hypothesis, we analyzed the expression of
commonly applied macrophage markers at early fracture healing
time-points (28–32). Therefore, we extracted hematoma/callus
tissue 3 and 7 days after osteotomy from young (3 months) and
aged (12 months), female rats. The aged animals served hereby
as a model system for impaired bone regeneration that develop
a non-union without additional treatment, as we have shown
previously (4, 20–22).
Interestingly, a diminished expression of monocyte/
macrophage related genes was detected in bone callus tissue
derived from aged animals, which develop a non-union when
no additional treatment is applied. The expression of the
monocyte/macrophage precursor marker CD14 and the general
macrophage marker CD68 were significantly downregulated
in bone callus tissue of aged animals, when compared to
their expression in callus tissue derived from young animals
(Figure 1A). Next, we investigated the expression of specific
M1 and M2 macrophage polarization markers in more detail,
considering the various processes, in which macrophage subsets
take part during healing cascades (10, 33). The M1 markers
FIGURE 3 | Transplantation of CD14+ macrophage precursors partly rescues impaired bone regeneration in aged rats. (A) Exemplary 3D reconstructions from four
individual animals receiving either PBMC or CD14+ cells locally at the osteotomy site. Bone healing was induced after CD14+ cell transplantation. (B) Mineral
deposition was prone to be increased after CD14+ cell transplantation in the investigated ROI. (C) Formation of new trabeculae was significantly induced after CD14+
cell transplantation as indicated by an increased number and a reduced space between them. Thickness of the single trabeculae were unaffected by cell
transplantation. n = 5, *significant to PBMC, p < 0.05, t-test.
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CD80 and CCR7 showed a significant upregulation in fracture
callus tissue of aged animals compared to young animals, at day
3 after osteotomy (Figure 1B). We further detected significant
alterations, when we investigated the expression of M2 specific
markers (Figure 1C). CD163, CD206, and Tie-2 showed lower
expression levels in bone callus tissue derived from aged animals
compared to younger ones (Figure 1C). These differences
reached significance on day 3 after osteotomy. The M2 marker
Dectin on the other hand, showed an upregulation from day
3 toward day 7 after osteotomy in young and aged animals.
However, its expression was significantly lower in callus tissue
from aged compared to young animals (Figure 1C). When
investigating unfractured contralateral bone tissue no significant
changes in marker gene expression levels could be detected
(Supplementary Figures 1A,B and Supplementary Table 1).
Disturbed Callus Revascularization in Aged
Rats
M2 macrophages are known to be highly involved in the
regulation of angiogenic responses (34, 35). We therefore
hypothesized, that the altered M2 macrophage expression profile
detected in bone callus of aged animals is further accompanied
with impaired revascularization of the injured bone tissue.
To this end, we investigated the expression of several pro-
angiogenic (growth) factors and their corresponding receptors.
Indeed, we found a significantly downregulated expression of
PDGFα, PDGFRα, HIF1α, and VEGFRα in fracture callus
tissue of aged animals 3 days after osteotomy compared to
tissue harvested from young ones (Figure 2A). PDGFβ and
its receptor PDGFRβ did not reach statistical significance but
showed the same trend of lower expression levels in fracture
calli from aged animals compared to young animals at day
3 (Figure 2A). Significantly lower expression of HIF1α and
VEGFRα was still evident 7 days after osteotomy in aged rats.
In addition, expression levels of PDGFβ, PDGFRβ, and VEGF
were significantly reduced at day 7 when comparing aged animals
to young ones (Figure 2A). The analyzed genes showed no
significant regulation in expression levels when investigating
control tissue (Supplementary Figure 1C).
The decreased expression of angiogenic growth factors in
aged animals is also reflected by a diminished number of newly
forming vessels, identified by immunohistochemical assessment.
Aged rats displayed 1.4-fold reduced numbers of alpha smooth
vessel actin (αSMA) positive vessels in the callus region compared
TABLE 3 | µCT investigations 6 weeks after cell transplantation.
PBMC CD14
TMC [mg HA] 15.13 ± 9.70 29.19 ± 16.32
BMC [mg HA] 12.99 ± 8.71 24.84 ± 16.58
BV [mm3 ] 14.95 ± 10.60 29.51 ± 18.50
Trabecular number [1/mm] 4.66 ± 1.44 6.45 ± 0.40
Trabecular space [mm] 0.34 ± 0.13 0.18 ± 0.02
Trabecular thickness [mm] 0.11 ± 0.02 0.13 ± 0.04
to young animals at day 3. At day 7 αSMA positive vessel
numbers were reduced by a factor of 2.5 in aged animals
(Figure 2B). Vessel diameter was also significantly reduced
in hematoma tissue derived from aged animals at day 7
(Supplementary Figure 2).
Monocyte Transplantation Rescues
Impaired Bone Healing in Aged Rats
Based on the findings discussed above, we assumed that
a diminished monocyte number and possibly decreased M2
macrophage differentiation or the lack of a shift from M1
to M2 population may lead to the observed delayed healing.
Enrichment of the naturally occurring monocyte/macrophage
CD14+ precursor cells in the osteotomy gap region of
aged animals may assist in steering a successful endogenous
healing cascade. Thus, local transplantation of CD14+ cells,
could improve the impaired bone regeneration observed in
aged animals.
Indeed, upon local transplantation of an artificial blood
clot containing CD14+ cells into the fracture gap of aged
animals directly after osteotomy-induced trauma, induction of
new bone formation was detected when compared to the control
group (artificial blood clot containing PBMCS) (Figure 3).
Reconstructions from µCT analysis showed a clear formation
of new bone tissue within the osteotomy gap (Figure 3A),
connected to a quantitatively increased mineral deposition in the
CD14+ enriched transplantation group compared to the PBMC
control group (Tissue Mineral Content-TMC, Bone Mineral
Content-BMC and Bone Volume-BV) (Table 3; Figure 3B).
When we investigated the microstructure of the newly formed
bone more in detail, we detected a significant increase in
trabecular number and a significantly diminished space between
the trabeculae (Table 3; Figures 3A,C).
Histological evaluations confirmed the findings from the
radiological analysis. A significant induction of new bone
tissue mainly proximal to the bone trauma and partly within
the gap region was detected in the CD14+ transplantation
group (Table 4; Figures 4A,B). By trend, we also found a
decreased formation of fibrous tissue, when CD14+ cells
were transplanted in aged animals (Table 4; Figures 4A,B).
Interestingly, the improved bone tissue regeneration after
TABLE 4 | Histomorphometric evaluations 6 weeks after cell transplantation.
PBMC CD14
Proximal Gap Distal Proximal Gap Distal
Mineralized
tissue









































12 ± 3 23 ± 14 14 ± 9 23 ± 15 55 ± 16 21 ± 9
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FIGURE 4 | Histological assessments verify improved bone healing after CD14+ cell transplantation aged rats. (A) Histomorphometric evaluations of mineralized,
fibrotic, and cartilage tissue with the osteotomy gap, as well as distal and proximal to it, were done. The analysis revealed a significant induced deposition of
mineralized bone matrix and by trend a diminished formation of fibrotic tissue, when aged animals received CD14+ cells locally at the osteotomy site. Number of
αSMA positive vessel increased significantly in the region of interest after CD14+ cell transplantation. PBMCs n = 5, CD14+ n = 7, *significant to PBMC, p < 0.05. (B)
Exemplary pictures of Movat-Pentachrom (mineralized bone, yellow/orange; collagen, yellow; cartilage, green/blue; osteoid, dark red; elastic fibers, orange/ref; nuclei,
blue-black) and aSMA stained tissue sections. Femurs are placed in the same orientation, with the proximal side on the left and distal on the right side. Bar = 500µm.
CD14+ cell transplantation was accompanied with a significant
induction of new vessel formation (Table 4; Figures 4A,B).
DISCUSSION AND CONCLUSION
Macrophages are essential for bone regeneration and they
participate in all stages of healing, promote collagen I deposition
and matrix mineralization by osteoblasts in vitro and in vivo
(9, 36, 37). Additional evidence that macrophages play important
roles during bone regeneration can be obtained from studies
reporting on systemic depletions of macrophages in experimental
mouse models. Independent of the time point of macrophage
depletion, a diminished formation of new bone matrix and an
altered endochondral ossification process is visible 7–28 days
after injury (36, 38).
The M1 to M2 switch plays a vital role during healing
progression as reported recently by co-workers from our institute
and others (19, 38). We confirm here that macrophage activity
plays a significant role in bone repair and that an imbalance
in the M1/M2 macrophage differentiation is associated with
disturbed bone regeneration in aged rats. Furthermore, we
showed that local transplantation of macrophage precursors can
enhance and potentially rescue bone repair under biologically
impaired conditions, presumably by an induction of M2
macrophage differentiation. Our findings highlight the potential
of local cell transplantations, here monocytes/macrophages to
steer bone repair, especially under compromised conditions,
since we used macrophage precursors derived from circulating
blood of aged matched donors for local cell transplantation,
which presumably shifted the endogenous cell balance and thus
promoted healing. Ongoing research further highlights a close
connection between macrophages and osteogenic differentiation.
A recent study, reported on the osteogenic differentiation
capacity of MC3T3 pre-osteoblasts in in vitro co-cultures with
macrophages (19). When MC3T3 cells were cultivated together
with M1 macrophages that underwent an IL-4 triggered M2
switch during MC3T3 osteoblast maturation, mineralized matrix
deposition was significantly induced (19). This might be due
to M2 macrophage-induced BMP-2 secretion, which is a major
contributor to osteogenic differentiation (39). In addition, recent
studies from Gibon et al. support our hypothesis of a disturbed
M1/M2 phenotype balance in aged. They could show that
bone marrow macrophages isolated from aged mice have a
higher pre-activated resting state and increased expression
of the pro-inflammatory cytokine TNFa after activation than
macrophages isolated from young animals (40). Furthermore,
they described an impaired M2 polarization of bone marrow
macrophages derived from aged mice (40). Recently Vi et al.
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also reported that the age of macrophages is crucial for fracture
repair. Parabiosis and fractionated bone marrow transplantation
experiments in mice showed that young macrophages can
rejunvenate healing potential of old bone marrow stromal cells,
while old macrophages impair healing of young bone marrow
stromal cells (41).
There is also in vivo evidence that M2 rather than
M1 macrophages regulate bone healing. Animals that were
administered with CSF-1, which is required for macrophage
differentiation, have an increased abundance of M2macrophages
within the fracture site and show improved healing outcomes
(36, 42). In addition, M2 macrophages are highly pro-angiogenic
and secrete various growth factors, as e.g., TGF-b, TGF-a,
bFGF, PDGF, and VEGF (43, 44). Thereby they might regulate
revascularization and matrix maturation of the callus tissue.
The angiogenic capacity of monocytes and their descendent
macrophages is also proven by investigations of Ccr2−/−
mice. Beside compromised cartilage maturation, Ccr2−/− mice
show an impaired formation of new blood vessels within
the fracture site (45). Moldovan et al. reported that the
angiogenic capacity of macrophages relates to their capability to
degrade extracellular matrix. Using a transgenic mouse model
of ischemic cardiomyopathy, where monocytes were attracted to
the myocardium by the targeted overexpression of CCL2, they
showed tunnel carving by macrophages, which provide growing
vessels with a path for invading capillaries (12).
However, there is still an ongoing discussion on the state of
macrophage polarization and activation and its effect on bone
regeneration. M1 macrophages for instance can be beneficial or
deleterious for bone formation, highly depending on the study
design as recently reviewed by Pajarinen et al. (9). Another
possibility is that all macrophage phenotypes can promote
osteogenesis, but that their effectiveness is connected to different
physiological and pathophysiological states (9).
Related to these recent reports and the current study, it is still
a matter of discussion whether the pro-regenerative function of
M2 macrophages in bone repair is related to their angiogenic
properties and/or their ability for matrix degradation and how
these characteristics may be effected by compromised biological
conditions. While our work gives new insights concerning the
beneficial effect of local macrophage enrichment on bone healing
outcome, it is limited in showing M1/M2 dynamics early after
transplantation. Additional research is needed to explore the
exact role of M2macrophages and other macrophage phenotypes
in the early healing cascade.
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